{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:02:17Z","timestamp":1791043337155,"version":"4.1.0"},"reference-count":138,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T00:00:00Z","timestamp":1749254400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019345","name":"King Salman Center for Disability Research","doi-asserted-by":"publisher","award":["KSRG-2024-261"],"award-info":[{"award-number":["KSRG-2024-261"]}],"id":[{"id":"10.13039\/501100019345","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejphar.2025.177830","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T18:53:54Z","timestamp":1749236034000},"page":"177830","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["LRP1 at the crossroads of Parkinson's and Alzheimer's: Divergent roles in \u03b1-synuclein and amyloid pathology"],"prefix":"10.1016","volume":"1002","author":[{"given":"Sultan M.","family":"Alshahrani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayder M.","family":"Al-kuraishy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali K.","family":"Albuhadily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa M.","family":"Shokr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sultan F.","family":"Kadasah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Alexiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios","family":"Papadakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaber","family":"El-Saber Batiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.177830_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113839","article-title":"Canagliflozin attenuates neurodegeneration and ameliorates dyskinesia through targeting the NLRP3\/Nurr1\/GSK-3\u03b2\/SIRT3 pathway and autophagy modulation in rotenone-lesioned rats","volume":"146","author":"Abdelaziz","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejphar.2025.177830_bib2","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4103\/IJCIIS.IJCIIS_7_20","article-title":"Statin therapy associated with decreased neuronal injury measured by serum S100\u03b2 levels in patients with acute ischemic stroke","volume":"11","author":"Al-Kuraishy","year":"2021","journal-title":"Int. J. Crit. Illn. Inj. Sci."},{"key":"10.1016\/j.ejphar.2025.177830_bib3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4103\/bbrj.bbrj_44_20","article-title":"Brain natriuretic peptide in patients with acute ischemic stroke: role of statins","volume":"4","author":"Al-Kuraishy","year":"2020","journal-title":"Biomed. Biotechnol. Res. J."},{"key":"10.1016\/j.ejphar.2025.177830_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/IJCIIS.IJCIIS_49_20","article-title":"Statin therapy improves serum annexin A1 levels in patients with acute coronary syndrome: a case-controlled study","volume":"11","author":"Al-Kuraishy","year":"2021","journal-title":"Int. J. Crit. Illn. Inj. Sci."},{"key":"10.1016\/j.ejphar.2025.177830_bib5","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.4103\/0028-3886.333482","article-title":"Statins therapy improves acute ischemic stroke in patients with cardio-metabolic disorders measured by lipoprotein-associated phospholipase A2 (Lp-PLA2): new focal point","volume":"69","author":"Al-Kuraishy","year":"2021","journal-title":"Neurol. India"},{"key":"10.1016\/j.ejphar.2025.177830_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14521","article-title":"Sleep disorders cause Parkinson's disease or the reverse is true: good GABA good night","volume":"30","author":"Al-kuraishy","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ejphar.2025.177830_bib7","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1007\/s10571-023-01350-8","article-title":"Parkinson's disease risk and hyperhomocysteinemia: the possible link","volume":"43","author":"Al-kuraishy","year":"2023","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2025.177830_bib8","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s10787-023-01400-z","article-title":"The effects of cholesterol and statins on Parkinson's neuropathology: a narrative review","volume":"32","author":"Al-kuraishy","year":"2024","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.ejphar.2025.177830_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/TJD.TJD_38_19","article-title":"Statins role in vitiligo: a mini-review","volume":"14","author":"Al-Kuraishy","year":"2020","journal-title":"Turkish J. Dermatology"},{"key":"10.1016\/j.ejphar.2025.177830_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102209","article-title":"New insight on the possible role of statins in vascular parkinsonism: a need for presumptive therapy","volume":"95","author":"Al-kuraishy","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejphar.2025.177830_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102075","article-title":"The conceivable role of prolactin hormone in parkinson disease: the same goal but with different ways","volume":"91","author":"Al-kuraishy","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejphar.2025.177830_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2025.111349","article-title":"Glutamatergic dysfunction in neurodegenerative diseases focusing on Parkinson's disease: role of glutamate modulators","volume":"225","author":"Almohmadi","year":"2025","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2025.177830_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/npr2.12445","article-title":"Role of uric acid in neurodegenerative diseases, focusing on alzheimer and parkinson disease: a new perspective","author":"Alrouji","year":"2024","journal-title":"Neuropsychopharmacology Reports"},{"key":"10.1016\/j.ejphar.2025.177830_bib14","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1007\/s10072-023-06926-2","article-title":"The potential role of cholesterol in Parkinson's disease neuropathology: perpetrator or victim","volume":"44","author":"Alrouji","year":"2023","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.ejphar.2025.177830_bib15","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3390\/brainsci12101290","article-title":"Statins use in alzheimer disease: Bane or boon from frantic search and narrative review","volume":"12","author":"Alsubaie","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.ejphar.2025.177830_bib16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.mcn.2013.06.004","article-title":"Role of the cannabinoid system in the transit of beta-amyloid across the blood-brain barrier","volume":"56","author":"Bachmeier","year":"2013","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177830_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176851","article-title":"Sigma-1 receptor modulation by clemastine highlights its repurposing as neuroprotective agent against seizures and cognitive deficits in PTZ-Kindled rats","volume":"980","author":"Badawi","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177830_bib18","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/1440-1681.13508","article-title":"Pentoxifylline prevents epileptic seizure via modulating HMGB1\/RAGE\/TLR4 signalling pathway and improves memory in pentylenetetrazol kindling rats","volume":"48","author":"Badawi","year":"2021","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejphar.2025.177830_bib19","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12760","article-title":"Impaired brain insulin signalling in Parkinson's disease","volume":"48","author":"Bassil","year":"2022","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.ejphar.2025.177830_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.108921","article-title":"Low levels of soluble low-density lipoprotein receptor-related protein 1 in patients with type 2 diabetes mellitus and diabetic retinopathy","author":"Batu Oto","year":"2022","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejphar.2025.177830_bib21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41583-023-00776-9","article-title":"Cell type-specific roles of APOE4 in alzheimer disease","volume":"25","author":"Blumenfeld","year":"2024","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177830_bib22","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3390\/app13020853","article-title":"Probing the interactions of LRP1 ectodomain-derived peptides with fibrillar tau protein and its impact on cellular internalization","volume":"13","author":"Boder","year":"2023","journal-title":"Appl. Sci."},{"key":"10.1016\/j.ejphar.2025.177830_bib23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fcell.2019.00031","article-title":"Low density receptor-related protein 1 interactions with the extracellular matrix: more than meets the eye","volume":"7","author":"Bres","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2025.177830_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106570","article-title":"Hepatic LRP-1 plays an important role in amyloidosis in Alzheimer's disease mice: potential role in chronic heavy alcohol feeding","volume":"199","author":"Chandrashekar","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2025.177830_bib25","article-title":"The dual role of low-density lipoprotein receptor-related protein 1 in atherosclerosis","volume":"8","author":"Chen","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ejphar.2025.177830_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-022-00560-w","article-title":"LRP1 is a neuronal receptor for \u03b1-synuclein uptake and spread","volume":"17","author":"Chen","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ejphar.2025.177830_bib27","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-022-00560-w","article-title":"LRP1 is a neuronal receptor for \u03b1-synuclein uptake and spread","author":"Chen","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ejphar.2025.177830_bib28","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.celrep.2012.09.030","article-title":"Monoacylglycerol lipase is a therapeutic target for alzheimer's disease","volume":"2","author":"Chen","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejphar.2025.177830_bib29","article-title":"Endocannabinoid 2-arachidonoylglycerol protects neurons against \u03b2-amyloid insults","author":"Chen","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2025.177830_bib30","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a024372","article-title":"The prion-like behavior of assembled tau in transgenic mice","volume":"7","author":"Clavaguera","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ejphar.2025.177830_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/alz.069020","article-title":"Investigating the binding of high molecular weight tau to LRP1","volume":"18","author":"Cooper","year":"2022","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.ejphar.2025.177830_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100715","article-title":"Regulation of tau internalization, degradation, and seeding by LRP1 reveals multiple pathways for tau catabolism","volume":"296","author":"Cooper","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.177830_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/alz.045959","article-title":"LRP1 mediates tau endocytosis in a process that is modulated by apolipoprotein E","volume":"16","author":"Cooper","year":"2020","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.ejphar.2025.177830_bib34","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s11064-014-1377-0","article-title":"PPAR\u03b3 and PGC-1\u03b1 as therapeutic targets in parkinson's","volume":"40","author":"Corona","year":"2015","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejphar.2025.177830_bib35","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.3390\/ijms19061780","article-title":"The role of low-density lipoprotein receptor-related protein 1 in lipid metabolism, glucose homeostasis and inflammation","volume":"19","author":"Dato","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177830_bib36","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00401-006-0115-3","article-title":"RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease","volume":"112","author":"Donahue","year":"2006","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejphar.2025.177830_bib37","doi-asserted-by":"crossref","DOI":"10.3233\/JPD-181474","article-title":"The emerging evidence of the parkinson pandemic","author":"Dorsey","year":"2018","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.ejphar.2025.177830_bib38","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.bbi.2012.07.003","article-title":"Inflammation-induced dysfunction of the low-density lipoprotein receptor-related protein-1 at the blood-brain barrier: protection by the antioxidant N-acetylcysteine","volume":"26","author":"Erickson","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ejphar.2025.177830_bib39","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1592\/phco.29.7.800","article-title":"Statin-associated adverse cognitive effects: survey results from 171 patients","volume":"29","author":"Evans","year":"2009","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejphar.2025.177830_bib40","article-title":"Mitigating seizure-induced cognitive deficits in mice induced with pentylenetetrazol by roflumilast through targeting the NLRP3 inflammasome\/BDNF\/SIRT3 pathway and regulating ferroptosis","volume":"366\u2013367","author":"Fawzy","year":"2025","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2025.177830_bib41","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3389\/fneur.2020.557509","article-title":"Commentary: LRP1 is a master regulator of tau uptake and spread","volume":"11","author":"Fearon","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ejphar.2025.177830_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011884","article-title":"Low-density lipoprotein receptor-related protein 1 (LRP1) mediates neuronal A\u03b242 uptake and lysosomal trafficking","volume":"5","author":"Fuentealba","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2025.177830_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2019.103390","article-title":"Amyloid-beta impairs insulin signaling by accelerating autophagy-lysosomal degradation of LRP-1 and IR-\u03b2 in blood-brain barrier endothelial cells in vitro and in 3XTg-AD mice","volume":"99","author":"Gali","year":"2019","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177830_bib44","doi-asserted-by":"crossref","DOI":"10.1097\/PR9.0000000000000898","article-title":"From the low-density lipoprotein receptor-related protein 1 to neuropathic pain: a potentially novel target","volume":"6","author":"Garc\u00eda-Fern\u00e1ndez","year":"2021","journal-title":"Pain Reports"},{"key":"10.1016\/j.ejphar.2025.177830_bib45","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/art.37893","article-title":"Brief report: attention deficit and hyperactivity disorder scores are elevated and respond to N-Acetylcysteine treatment in patients with systemic lupus erythematosus","volume":"65","author":"Garcia","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2025.177830_bib46","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s12035-019-01714-6","article-title":"The interaction between neuroinflammation and \u03b2-Amyloid in cognitive decline in parkinson's disease","volume":"57","author":"Ghadery","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2025.177830_bib47","first-page":"1475","article-title":"An update on the current and emerging use of thiazolidinediones for type 2 diabetes","volume":"58","author":"Giglio","year":"2022","journal-title":"M\u00e9d. Sur"},{"key":"10.1016\/j.ejphar.2025.177830_bib48","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.nicl.2014.01.016","article-title":"LRP-1 polymorphism is associated with global and regional amyloid load in Alzheimer's disease in humans in-vivo","volume":"4","author":"Grimmer","year":"2014","journal-title":"NeuroImage Clin"},{"key":"10.1016\/j.ejphar.2025.177830_bib49","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.brainresbull.2021.05.011","article-title":"Effect of lobeglitazone on motor function in rat model of Parkinson's disease with diabetes co-morbidity","volume":"173","author":"Hassanzadeh","year":"2021","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2025.177830_bib50","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1089\/ars.2024.0674","article-title":"Cholesterol metabolism in neurodegenerative diseases","volume":"41","author":"He","year":"2024","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejphar.2025.177830_bib51","series-title":"Pharmacology and Clinical Effects of N-acetylcysteine in Neurodegenerative Disorders","author":"Holmay","year":"2015"},{"key":"10.1016\/j.ejphar.2025.177830_bib52","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s12035-022-03119-4","article-title":"Endothelial LRP1-ICD accelerates cognition-associated alpha-synuclein pathology and neurodegeneration through PARP1 activation in a mouse model of parkinson's disease","volume":"60","author":"Huang","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2025.177830_bib53","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1093\/brain\/awab478","article-title":"APOE4 derived from astrocytes leads to blood-brain barrier impairment","volume":"145","author":"Jackson","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.ejphar.2025.177830_bib54","doi-asserted-by":"crossref","DOI":"10.5530\/ijper.53.4.133","article-title":"Neuroprotective and antiapoptotic effects of N-acetylcystein and crocus sativus aqueous extract on arsenic-induced neurotoxicity in SH-SY5Y human dopaminergic neuroblastoma cells","author":"Jahromi","year":"2019","journal-title":"Indian J. Pharm. Educ. Res."},{"key":"10.1016\/j.ejphar.2025.177830_bib55","doi-asserted-by":"crossref","first-page":"554","DOI":"10.5607\/en.2019.28.5.554","article-title":"Cholesterol metabolism in the brain and its association with Parkinson's disease","volume":"28","author":"Jin","year":"2019","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.ejphar.2025.177830_bib56","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/alz.068875","article-title":"APOE4 exacerbates \u03b1-synuclein seeding activity and contributes to neurotoxicity in Alzheimer's disease with lewy body pathology","volume":"18","author":"Jin","year":"2022","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.ejphar.2025.177830_bib57","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3390\/brainsci8100185","article-title":"N-acetyl cysteine supplement minimize tau expression and neuronal loss in animal model of alzheimer's disease","volume":"8","author":"Joy","year":"2018","journal-title":"Brain Sci."},{"key":"10.1016\/j.ejphar.2025.177830_bib58","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fnagi.2014.00093","article-title":"The low-density lipoprotein receptor-related protein 1 and amyloid-\u03b2 clearance in Alzheimer's disease","volume":"6","author":"Kanekiyo","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ejphar.2025.177830_bib59","doi-asserted-by":"crossref","first-page":"16458","DOI":"10.1523\/JNEUROSCI.3987-12.2012","article-title":"Lrp1 in brain vascular smooth muscle cells mediates local clearance of Alzheimer's amyloid-\u03b2","volume":"32","author":"Kanekiyo","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177830_bib60","doi-asserted-by":"crossref","first-page":"8311","DOI":"10.3390\/ijms23158311","article-title":"Neuronal ApoE regulates the cell-to-cell transmission of \u03b1-Synuclein","volume":"23","author":"Kang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177830_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177419","article-title":"Dysregulation of serotonergic neurotransmission in parkinson disease: a key duet","volume":"995","author":"Khowdiary","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177830_bib62","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.3390\/molecules26102838","article-title":"The effects of statins on neurotransmission and their neuroprotective role in neurological and psychiatric disorders","volume":"26","author":"Kosowski","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2025.177830_bib63","first-page":"1","article-title":"Blood\u2013brain barrier alterations and their impact on Parkinson's disease pathogenesis and therapy","volume":"131 13","author":"Lau","year":"2024","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.ejphar.2025.177830_bib64","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.toxlet.2012.07.016","article-title":"Rosiglitazone, a PPAR-\u03b3 agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats","volume":"213","author":"Lee","year":"2012","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejphar.2025.177830_bib65","article-title":"Insights into the role of platelet-derived growth factors: implications for parkinson's disease pathogenesis and treatment","volume":"14","author":"Li","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ejphar.2025.177830_bib66","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1007\/s00415-018-9100-8","article-title":"Amyloid-\u03b2 and Parkinson's disease on behalf of kings parcog groupMDS nonmotor study group","volume":"266","author":"Lim","year":"2019","journal-title":"J. Neurol."},{"key":"10.1016\/j.ejphar.2025.177830_bib67","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.30498","article-title":"LRP1 regulates peroxisome biogenesis and cholesterol homeostasis in oligodendrocytes and is required for proper CNS myelin development and repair","volume":"6","author":"Lin","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.ejphar.2025.177830_bib68","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.1523\/JNEUROSCI.5180-14.2015","article-title":"Neuronal LRP1 regulates glucose metabolism and insulin signaling in the brain","volume":"35","author":"Liu","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177830_bib69","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fnins.2019.00043","article-title":"The role of NMDA receptors in Alzheimer's disease","volume":"13","author":"Liu","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177830_bib70","doi-asserted-by":"crossref","first-page":"17068","DOI":"10.1523\/JNEUROSCI.4067-10.2010","article-title":"Neuronal LRP1 knockout in adult mice leads to impaired brain lipid metabolism and progressive, age-dependent synapse loss and neurodegeneration","volume":"30","author":"Liu","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177830_bib71","doi-asserted-by":"crossref","first-page":"27303","DOI":"10.1074\/jbc.M413969200","article-title":"Low density lipoprotein receptor-related protein (LRP) interacts with presenilin 1 and is a competitive substrate of the amyloid precursor protein (APP) for \u03b3-secretase","volume":"280","author":"Lle\u00f3","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.177830_bib72","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1002\/cmdc.202100177","article-title":"Thiazolidinediones: an In\u2013Depth study of their synthesis and application to medicinal chemistry in the treatment of diabetes mellitus","volume":"16","author":"Long","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejphar.2025.177830_bib73","first-page":"10","article-title":"Low-density lipoprotein receptor-related protein 1 mediates \u03b1-synuclein transmission from the striatum to the substantia nigra in animal models of Parkinson's disease","author":"Luo","year":"2024","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ejphar.2025.177830_bib74","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1021\/acschemneuro.8b00383","article-title":"Alpha-synuclein in peripheral tissues in parkinson's disease","volume":"10","author":"Ma","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177830_bib75","doi-asserted-by":"crossref","first-page":"34009","DOI":"10.1074\/jbc.M113.509133","article-title":"LRP1 assembles unique co-receptor systems to initiate cell signaling in response to tissue-type plasminogen activator and Myelin-associated glycoprotein","volume":"288","author":"Mantuano","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.177830_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100842","article-title":"Molecular chaperone RAP interacts with LRP1 in a dynamic bivalent mode and enhances folding of ligand-binding regions of other LDLR family receptors","volume":"297","author":"Marakasova","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.177830_bib77","doi-asserted-by":"crossref","first-page":"4","DOI":"10.36959\/734\/367","article-title":"N-Acetylcysteine: a natural antidote for alzheimer's disease","volume":"1","author":"Marcos","year":"2016","journal-title":"Alzheimers Dis. Dement."},{"key":"10.1016\/j.ejphar.2025.177830_bib78","first-page":"21","article-title":"Prevalence of Parkinson's disease across North America","volume":"4","author":"Marras","year":"2018","journal-title":"Park. Dis."},{"key":"10.1016\/j.ejphar.2025.177830_bib79","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3390\/antiox11020416","article-title":"N-Acetyl-Cysteine: modulating the cysteine redox proteome in neurodegenerative diseases","volume":"11","author":"Martinez-Banaclocha","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejphar.2025.177830_bib80","article-title":"Proteomic analysis of human chylomicron remnants isolated by apolipoprotein B-48 immunoprecipitation","volume":"64920","author":"Masuda","year":"2024","journal-title":"J. Atherosclerosis Thromb."},{"key":"10.1016\/j.ejphar.2025.177830_bib81","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13041-022-00964-1","article-title":"Beta amyloid deposition and cognitive decline in Parkinson's disease: a study of the PPMI cohort","volume":"15","author":"Mihaescu","year":"2022","journal-title":"Mol. Brain"},{"key":"10.1016\/j.ejphar.2025.177830_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2022.102294","article-title":"Protective effect of N-acetyl cysteine on the mitochondrial dynamic imbalance in temporal lobe epilepsy: possible role of mTOR","volume":"96","author":"Mohammadi","year":"2022","journal-title":"Neuropeptides"},{"key":"10.1016\/j.ejphar.2025.177830_bib83","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.metabol.2010.08.013","article-title":"Up-regulation of hepatic low-density lipoprotein receptor-related protein 1: a possible novel mechanism of antiatherogenic activity of hydroxymethylglutaryl-coenzyme A reductase inhibitor: Atorvastatin and hepatic LRP1 expression","volume":"60","author":"Moon","year":"2011","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.ejphar.2025.177830_bib84","doi-asserted-by":"crossref","first-page":"14308","DOI":"10.1074\/jbc.M109.046672","article-title":"Low density lipoprotein receptor-related protein 1 (LRP1) forms a signaling complex with platelet-derived growth factor receptor-\u03b2 in endosomes and regulates activation of the MAPK pathway","volume":"285","author":"Muratoglu","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.177830_bib85","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/neup.12204","article-title":"Isopentenyl diphosphate isomerase, a cholesterol synthesizing enzyme, is localized in lewy bodies","volume":"35","author":"Nakamura","year":"2015","journal-title":"Neuropathology"},{"key":"10.1016\/j.ejphar.2025.177830_bib86","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1471-4159.1997.68020587.x","article-title":"The low-density lipoprotein receptor-related protein, a multifunctional apolipoprotein E receptor, modulates hippocampal neurite development","volume":"68","author":"Narita","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2025.177830_bib87","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1038\/s41593-023-01480-8","article-title":"The APOE-R136S mutation protects against APOE4-driven tau pathology, neurodegeneration and neuroinflammation","volume":"26","author":"Nelson","year":"2023","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177830_bib88","article-title":"LRP1-mediated p-tau propagation contributes to cognitive impairment after chronic neuropathic pain in rats","author":"Ning","year":"2024","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.ejphar.2025.177830_bib89","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1080\/00207454.2022.2131552","article-title":"Soluble LRP-1 in Parkinson's disease: clues for paradoxical effects","volume":"134","author":"Ozdilek","year":"2024","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177830_bib90","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13024-022-00582-4","article-title":"LRP1: a novel receptor for the transmission of pathological \u03b1-Synuclein","volume":"17","author":"Pan","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ejphar.2025.177830_bib91","doi-asserted-by":"crossref","first-page":"8921","DOI":"10.3390\/ijms23168921","article-title":"Low-density lipoprotein receptor-related protein 8 at the crossroad between cancer and neurodegeneration","volume":"23","author":"Passarella","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177830_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101121","article-title":"LRP1 activation attenuates white matter injury by modulating microglial polarization through Shc1\/PI3K\/Akt pathway after subarachnoid hemorrhage in rats","volume":"21","author":"Peng","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2025.177830_bib93","doi-asserted-by":"crossref","first-page":"948","DOI":"10.3390\/pharmaceutics16070948","article-title":"Low-density lipoprotein receptor-related protein 1 as a potential therapeutic target in alzheimer's disease","volume":"16","author":"Petralla","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejphar.2025.177830_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/cells12232763","article-title":"LRP1 and RAGE genes transporting amyloid and tau protein in the hippocampal CA3 area in an ischemic model of alzheimer's disease with 2-Year survival","volume":"12","author":"Pluta","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2025.177830_bib95","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-92711-0","article-title":"Low-density lipoprotein receptor-related protein 1 (LRP1) is a novel receptor for apolipoprotein A4 (APOA4) in adipose tissue","volume":"11","author":"Qu","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.177830_bib96","first-page":"1202","article-title":"The multifaceted therapeutic role of N-Acetylcysteine (NAC) in disorders characterized by oxidative stress","volume":"19","author":"Raghu","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejphar.2025.177830_bib97","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.neuroscience.2024.12.059","article-title":"Statins for vascular dementia: a hype or hope","volume":"567","author":"Rajab","year":"2025","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2025.177830_bib98","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3389\/fnagi.2015.00136","article-title":"Impaired vascular-mediated clearance of brain amyloid beta in Alzheimer's disease: the role, regulation and restoration of LRP1","volume":"7","author":"Ramanathan","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ejphar.2025.177830_bib99","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1093\/brain\/awac414","article-title":"Association between the LRP1B and APOE loci and the development of Parkinson's disease dementia","volume":"146","author":"Real","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.ejphar.2025.177830_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-021-01136-3","article-title":"Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson's disease","volume":"9","author":"Reyes","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ejphar.2025.177830_bib101","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3389\/fphar.2017.00772","article-title":"High concentrations of rosiglitazone reduce mRNA and protein levels of LRP1 in HepG2 cells","volume":"8","author":"Rond\u00f3n-Ortiz","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177830_bib102","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.3390\/nu15163585","article-title":"The molecular mechanisms of the relationship between insulin resistance and parkinson's disease pathogenesis","volume":"15","author":"Ruiz-Pozo","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.ejphar.2025.177830_bib103","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3233\/JAD-2010-101248","article-title":"Impaired lipoprotein receptor-mediated peripheral binding of plasma amyloid-\u03b2 is an early biomarker for mild cognitive impairment preceding alzheimer's disease","volume":"24","author":"Sagare","year":"2011","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.ejphar.2025.177830_bib104","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3389\/fnins.2017.00712","article-title":"Apolipoprotein E\u03b54: a biomarker for executive dysfunction among Parkinson's disease patients with mild cognitive impairment","volume":"11","author":"Samat","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177830_bib105","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s12035-020-02114-x","article-title":"Overexpression of \u03b1-Synuclein reorganises growth factor profile of human astrocytes","volume":"58","author":"\u015eeng\u00fcl","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2025.177830_bib106","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-40736-x","article-title":"Low-dose pioglitazone can ameliorate learning and memory impairment in a mouse model of dementia by increasing LRP1 expression in the hippocampus","volume":"9","author":"Seok","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.177830_bib107","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1672","article-title":"Alzheimer's amyloid-\u03b2 and tau protein accumulation is associated with decreased expression of the LDL receptor-associated protein in human brain tissue","volume":"10","author":"Shepherd","year":"2020","journal-title":"Brain Behav"},{"key":"10.1016\/j.ejphar.2025.177830_bib108","doi-asserted-by":"crossref","first-page":"22091","DOI":"10.1074\/jbc.M110.102277","article-title":"Reduction of brain \u03b2-amyloid (A\u03b2) by fluvastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, through increase in degradation of amyloid precursor protein C-terminal fragments (APP-CTFs) and A\u03b2 clearance","volume":"285","author":"Shinohara","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.177830_bib109","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/brain\/awab446","article-title":"Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state","volume":"145","author":"Smajic","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.ejphar.2025.177830_bib110","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.3390\/antiox11112168","article-title":"ApoE3 vs. ApoE4 astrocytes: a detailed analysis provides new insights into differences in cholesterol homeostasis","volume":"11","author":"Staurenghi","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejphar.2025.177830_bib111","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1172\/JCI81108","article-title":"Endothelial LRP1 transports amyloid-\u03b21-42 across the blood-brain barrier","volume":"126","author":"Storck","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2025.177830_bib112","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/aps.2014.161","article-title":"Atorvastatin prevents A\u03b2 oligomer-induced neurotoxicity in cultured rat hippocampal neurons by inhibiting tau cleavage","volume":"36","author":"Sui","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2025.177830_bib113","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.peptides.2014.09.018","article-title":"Alpha synuclein is transported into and out of the brain by the blood-brain barrier","volume":"62","author":"Sui","year":"2014","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2025.177830_bib114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2015.12.003","article-title":"Rescuing effects of RXR agonist bexarotene on aging-related synapse loss depend on neuronal LRP1","volume":"277","author":"Tachibana","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2025.177830_bib115","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1177\/08919887211060019","article-title":"APOE4 allele, sex, and dementia risk in parkinson's disease: lessons from a longitudinal cohort","volume":"35","author":"Umeh","year":"2022","journal-title":"J. Geriatr. Psychiatr. Neurol."},{"key":"10.1016\/j.ejphar.2025.177830_bib116","doi-asserted-by":"crossref","first-page":"7234","DOI":"10.1007\/s12035-019-1594-2","article-title":"LRP1 has a predominant role in production over clearance of A\u03b2 in a mouse model of alzheimer's disease","volume":"56","author":"Van Gool","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2025.177830_bib117","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.parkreldis.2021.07.032","article-title":"Digital health technology for non-motor symptoms in people with Parkinson's disease: futile or future?","volume":"89","author":"van Wamelen","year":"2021","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.ejphar.2025.177830_bib118","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000234913","article-title":"Genetic Interaction between Tau and the Apolipoprotein e Receptor LRP1 Increases Alzheimer's Disease Risk","volume":"28","author":"V\u00e1zquez-Higuera","year":"2009","journal-title":"Dement. Geriatr. Cogn. Disord"},{"key":"10.1016\/j.ejphar.2025.177830_bib119","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3233\/JAD-160763","article-title":"Role of glutamate and NMDA receptors in alzheimer's disease","volume":"57","author":"Wang","year":"2017","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.ejphar.2025.177830_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2025.102751","article-title":"Down-regulation of platelet-derived growth factor receptor \u03b2 in pericytes increases blood-brain barrier permeability and significantly enhances \u03b1-synuclein in a Parkinson's disease 3D cell model in vitro under hyperglycemic condition","volume":"93","author":"Wang","year":"2025","journal-title":"Tissue Cell"},{"key":"10.1016\/j.ejphar.2025.177830_bib121","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.ajpath.2011.07.021","article-title":"Apolipoprotein e and LRP1 increase early in Parkinson's disease pathogenesis","volume":"179","author":"Wilhelmus","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2025.177830_bib122","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/jamaneurol.2017.3713","article-title":"Associations between tau, \u03b2-amyloid, and cognition in parkinson disease","volume":"75","author":"Winer","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ejphar.2025.177830_bib123","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247357","article-title":"A phase 1 clinical trial of SP16, a first-in-class anti-inflammatory LRP1 agonist, in healthy volunteers","volume":"16","author":"Wohlford","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2025.177830_bib124","series-title":"Developing Therapeutics for Alzheimer's Disease: Progress and Challenges, Developing Therapeutics for Alzheimer's Disease: Progress and Challenges","author":"Wolfe","year":"2016"},{"key":"10.1016\/j.ejphar.2025.177830_bib125","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s12640-018-9895-1","article-title":"Clearance of amyloid beta and tau in alzheimer's disease: from mechanisms to therapy","volume":"34","author":"Xin","year":"2018","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejphar.2025.177830_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2022.136810","article-title":"Mesenchymal stem cell-derived exosomes altered neuron cholesterol metabolism via Wnt5a-LRP1 axis and alleviated cognitive impairment in a progressive Parkinson's disease model","volume":"787","author":"Xu","year":"2022","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2025.177830_bib127","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.matbio.2022.08.007","article-title":"A top-down approach to uncover the hidden ligandome of low-density lipoprotein receptor-related protein 1 in cartilage","volume":"112","author":"Yamamoto","year":"2022","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ejphar.2025.177830_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107521","article-title":"Novel insights into the multifaceted and tissue-specific roles of the endocytic receptor LRP1","volume":"300","author":"Yamamoto","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.177830_bib129","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8729398","article-title":"Activation of LRP1 ameliorates cerebral ischemia\/reperfusion injury and cognitive decline by suppressing neuroinflammation and oxidative stress through TXNIP\/NLRP3 signaling pathway in mice","volume":"2022","author":"Yang","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2025.177830_bib130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-016-0772-7","article-title":"LRP1 modulates the microglial immune response via regulation of JNK and NF-\u039aB signaling pathways","volume":"13","author":"Yang","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejphar.2025.177830_bib131","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bbalip.2017.09.008","article-title":"Regulatory effects of simvastatin and apoJ on APP processing and amyloid-\u03b2 clearance in blood-brain barrier endothelial cells","volume":"1863","author":"Zandl-Lang","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.ejphar.2025.177830_bib132","doi-asserted-by":"crossref","first-page":"5668","DOI":"10.3390\/molecules26185668","article-title":"Targeting monoacylglycerol lipase in pursuit of therapies for neurological and neurodegenerative diseases","volume":"26","author":"Zanfirescu","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2025.177830_bib133","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/biof.1283","article-title":"Prolidase-proline dehydrogenase\/proline oxidase-collagen biosynthesis axis as a potential interface of apoptosis\/autophagy","volume":"42","author":"Zareba","year":"2016","journal-title":"Biofactors"},{"key":"10.1016\/j.ejphar.2025.177830_bib134","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1007\/s12035-017-0689-x","article-title":"Alleviation of neuropathology by inhibition of monoacylglycerol lipase in APP transgenic mice lacking CB2 receptors","volume":"55","author":"Zhang","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"8","key":"10.1016\/j.ejphar.2025.177830_bib135","first-page":"1","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"81","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2025.177830_bib136","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3389\/fneur.2018.00809","article-title":"Tau pathology in Parkinson's disease","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ejphar.2025.177830_bib137","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1515\/revneuro-2015-0069","article-title":"The role of the low-density lipoprotein receptor-related protein 1 (LRP-1) in regulating blood-brain barrier integrity","volume":"27","author":"Zhao","year":"2016","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177830_bib138","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2174\/1567205018666210906092940","article-title":"Effect of high cholesterol regulation of LRP1 and RAGE on A\u03b2 transport across the blood-brain barrier in alzheimer's disease","volume":"18","author":"Zhou","year":"2021","journal-title":"Curr. Alzheimer Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925005849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925005849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:22:50Z","timestamp":1778876570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925005849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":138,"alternative-id":["S0014299925005849"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177830","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LRP1 at the crossroads of Parkinson's and Alzheimer's: Divergent roles in \u03b1-synuclein and amyloid pathology","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177830","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"177830"}}